| # | Drug | Count |
|---|---|---|
| 0 | DAPAGLIFLOZIN | 73 |
| 1 | METFORMIN | 46 |
| 2 | METFORMIN ER 500 MG | 46 |
| 3 | METFORMIN ER 750 MG | 46 |
| 4 | EMPAGLIFLOZIN | 37 |
| 5 | INSULIN GLARGINE | 31 |
| 6 | METFORMIN HYDROCHLORIDE | 29 |
| 7 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 28 |
| 8 | METFORMIN HYDROCHLORIDE TABLET | 28 |
| 9 | METFORMIN HYDROCHLORIDE TABLETS | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERTUGLIFLOZIN | 24 | 0.0215 |
| 1 | NICARDIPINE HYDROCHLORIDE | 8 | 0.0036 |
| 2 | ACARBOSE | 13 | 0.0033 |
| 3 | SODIUM HYALURONATE | 2 | 0.0024 |
| 4 | SITAGLIPTIN PHOSPHATE | 5 | 0.0018 |
| 5 | NICARDIPINE | 8 | 0.0018 |
| 6 | SOTAGLIFLOZIN | 1 | 0.0018 |
| 7 | PIOGLITAZONE HYDROCHLORIDE | 2 | 0.0016 |
| 8 | DAPAGLIFLOZIN | 73 | 0.0012 |
| 9 | INSULIN ASPART INJECTION | 3 | 0.0011 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Glucosidase Inhibitor [EPC] | 14 | 0.0029 |
| 1 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 109 | 0.0010 |
| 2 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 3 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 13 | 0.0004 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 13 | 0.0003 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 17 | 0.0002 |
| 7 | Insulin Analog [EPC] | 61 | 0.0001 |
| 8 | GLP-1 Receptor Agonist [EPC] | 56 | 0.0001 |
| 9 | Sulfonylurea [EPC] | 14 | 0.0001 |